Sildenafil improves how muscles work when patients with cystic fibrosis (CF) exercise and this translates into better exercise capacity,…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Vitamin D intoxication may occur in people with cystic fibrosis (CF) due to accidental errors made by pharmacists in…
People with cystic fibrosis (CF) generally are living longer and healthier lives than in the recent past. Now, researchers…
To mark its 10th anniversary, Claire’s Place Foundation has launched a website that seeks to connect the community of…
Olgram has raised €1.5 million (about $1.77 million) in seed funding from investors to speed its development of antibiotics…
Health regulators in Australia have approved Trikafta (elexacaftor/tezacaftor/ivacaftor) to treat people with cystic fibrosis (CF), ages 12 years…
Trikafta, a medication that combines three different therapies (elexacaftor/tezacaftor/ivacaftor), is safe and effective in children with cystic fibrosis…
Parents of children and young adults with cystic fibrosis (CF) in Ontario sent a video appeal to the head…
Two bacterial species known to be frequent sources of lung infection in people with cystic fibrosis (CF) —…